about
Self-assembled nanoparticles based on modified cationic dipeptides and DNA: novel systems for gene deliveryNonionic surfactant vesicles composed of novel spermine-derivative cationic lipids as an effective gene carrier in vitro.Positron-emission tomography reporter gene expression imaging in rat myocardium.Gene transfection efficacy assessment of human cervical cancer cells using dual-mode fluorescence microendoscopyDefensive applications of gene transfer technology in the face of bioterrorism: DNA-based vaccines and immune targeting.Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticlesVascular-targeted cancer gene therapy.Prenyl Ammonium Salts--New Carriers for Gene Delivery: A B16-F10 Mouse Melanoma Model.Gene therapy in urology: strategies to translate theory into practice.Positron emission tomography reporter gene imaging in the myocardium: for monitoring of angiogenic gene therapy in ischemic heart disease.Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours.Carbon nanotubes: potential medical applications and safety concerns.A review of food-grade vectors in lactic acid bacteria: from the laboratory to their application.Cationic niosomes an effective gene carrier composed of novel spermine-derivative cationic lipids: effect of central core structures.Structure relationship of cationic lipids on gene transfection mediated by cationic liposomes.Cationic niosomes composed of spermine-based cationic lipids mediate high gene transfection efficiency.Inhibitory effect of Survivin promoter-regulated oncolytic adenovirus carrying P53 gene against gallbladder cancer.Dynamic properties of an oriented lipid/DNA complex studied by neutron scattering.Novel dextran-spermine conjugates as transfecting agents: comparing water-soluble and micellar polymers.Cationic liposomes for gene transfection.Inclusion of a single-tail amino acid-based amphiphile in a lipoplex formulation: effects on transfection efficiency and physicochemical properties.Intrinsic bio-signature of gene delivery nanocarriers may impair gene therapy goals.The Gordon Wilson lecture: using genetic medicine to regenerate diseased organs and protect against the hostile environment.Regulated, electroporation-mediated delivery of pro-opiomelanocortin gene suppresses chronic constriction injury-induced neuropathic pain in rats.Adeno-associated virus vectors simultaneously encoding VEGF and angiopoietin-1 enhances neovascularization in ischemic rabbit hind-limbs.Peptide-Based Supramolecular Hydrogels for Delivery of Biologics.
P2860
Q21245651-DE040400-A5FB-4638-9386-E724A9163957Q33681199-A03AEBF1-F634-45A2-9153-EAE1AAF409E9Q34077922-01024957-AE3B-4F3A-86B2-060F0279AC9AQ34543520-C6423C78-CC9F-465C-8DFB-378871BB19BBQ35594090-9A467B36-FFF0-41BA-BD68-14366F4856F3Q35846835-AEECB555-9963-4891-BB79-EE3A6EC8B254Q35967282-60CD7CC5-198E-456B-9318-2C3E537C9ABFQ35992432-1FF48153-FFB2-409C-8EF5-358BA0EF52F0Q36312228-01D99B21-E21D-4A8D-A8A3-904F334EF205Q36321294-6EFB1CC7-F1E1-4177-B11A-A5AB5E73BEE4Q36327049-E74B8618-E1C7-435F-AA28-782F20043426Q38272075-92BAA301-0217-4188-B257-DEB0FDDE4A56Q38751357-DC95FC7C-6825-489E-A43A-651B70F28AEAQ38808635-0408286D-B1C2-46D2-AF9D-02BABCA487A7Q39272670-A02FC62F-A0EE-4715-9636-4C02D6E95954Q39288880-FE086A62-C7C5-4A68-9664-23FD34DC564BQ39451790-BA17896A-6E40-474E-8A7A-6349A7E54199Q40315736-690C6B0A-A958-449B-8377-983EFF88C485Q40487818-CE05EABB-3BDB-46BE-B485-DAABE1B7882FQ40544048-398AC2A6-12A4-4903-A861-EBC1E44A65A8Q41616582-D929B930-EA23-4301-B07C-02D22929E170Q42259491-A50C7CB5-EB14-46F6-A3D8-D60B125E68EDQ43070160-C1361602-5895-4401-8D6F-7F9384851BA4Q44872856-A8863024-3DAC-4258-BF2A-2332C3087476Q45406014-AEBF9AEB-6D3C-402B-8419-582F4BA0542FQ55656986-87451D7C-1541-4E19-9EAA-59436D3453C5
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The future of human gene therapy.
@ast
The future of human gene therapy.
@en
The future of human gene therapy.
@nl
type
label
The future of human gene therapy.
@ast
The future of human gene therapy.
@en
The future of human gene therapy.
@nl
prefLabel
The future of human gene therapy.
@ast
The future of human gene therapy.
@en
The future of human gene therapy.
@nl
P1476
The future of human gene therapy.
@en
P2093
Rubanyi GM
P304
P356
10.1016/S0098-2997(01)00004-8
P577
2001-06-01T00:00:00Z